Alessandra Mosca

3.8k total citations · 1 hit paper
62 papers, 2.3k citations indexed

About

Alessandra Mosca is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Alessandra Mosca has authored 62 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Pulmonary and Respiratory Medicine, 20 papers in Molecular Biology and 14 papers in Oncology. Recurrent topics in Alessandra Mosca's work include Prostate Cancer Treatment and Research (22 papers), Renal cell carcinoma treatment (15 papers) and Neuroendocrine Tumor Research Advances (8 papers). Alessandra Mosca is often cited by papers focused on Prostate Cancer Treatment and Research (22 papers), Renal cell carcinoma treatment (15 papers) and Neuroendocrine Tumor Research Advances (8 papers). Alessandra Mosca collaborates with scholars based in Italy, United States and United Kingdom. Alessandra Mosca's co-authors include Camillo Porta, Chiara Paglino, Luigi Dogliotti, Alberto Angeli, M. Torta, R. Tarabuzzi, Alfredo Berruti, Enrico Bollito, Dario Fontana and Roberto Mario Scarpa and has published in prestigious journals such as Journal of Clinical Oncology, Water Research and Cancer.

In The Last Decade

Alessandra Mosca

59 papers receiving 2.3k citations

Hit Papers

Targeting PI3K/Akt/mTOR Signaling in Cancer 2014 2026 2018 2022 2014 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Targeting PI3K/Akt/mTOR Signaling in Cancer
    2014 1.2k citations Camillo Porta, Alessandra Mosca et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alessandra Mosca Italy 20 1.0k 788 571 450 327 62 2.3k
Li Cai China 32 1.7k 1.7× 524 0.7× 807 1.4× 802 1.8× 349 1.1× 159 3.3k
Mauro Bologna Italy 36 1.7k 1.7× 789 1.0× 1.1k 1.9× 722 1.6× 135 0.4× 116 3.5k
Jie Liu China 32 1.4k 1.4× 381 0.5× 1.1k 1.9× 420 0.9× 152 0.5× 183 3.2k
Mohd W. Nasser United States 35 1.7k 1.7× 387 0.5× 983 1.7× 828 1.8× 199 0.6× 72 3.5k
Hiroshi Matsui Japan 26 632 0.6× 619 0.8× 331 0.6× 282 0.6× 130 0.4× 140 1.9k
Wassim Abou‐Kheir Lebanon 33 1.4k 1.4× 545 0.7× 740 1.3× 800 1.8× 209 0.6× 113 3.2k
Alessandra Ghigo Italy 30 1.3k 1.3× 359 0.5× 441 0.8× 175 0.4× 209 0.6× 86 2.9k
Xiao‐Feng Zhu China 26 1.4k 1.4× 536 0.7× 426 0.7× 624 1.4× 416 1.3× 105 2.5k
Chong Zhang China 26 1.2k 1.2× 837 1.1× 376 0.7× 477 1.1× 137 0.4× 128 2.6k
Songqing He China 30 1.2k 1.2× 212 0.3× 378 0.7× 622 1.4× 440 1.3× 108 2.4k

Countries citing papers authored by Alessandra Mosca

Since Specialization
Citations

This map shows the geographic impact of Alessandra Mosca's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alessandra Mosca with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alessandra Mosca more than expected).

Fields of papers citing papers by Alessandra Mosca

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alessandra Mosca. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alessandra Mosca. The network helps show where Alessandra Mosca may publish in the future.

Co-authorship network of co-authors of Alessandra Mosca

This figure shows the co-authorship network connecting the top 25 collaborators of Alessandra Mosca. A scholar is included among the top collaborators of Alessandra Mosca based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alessandra Mosca. Alessandra Mosca is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gerónimo, Eduardo De, Alessandra Mosca, Franco M. Cabrerizo, & Rodrigo Vargas. (2025). Insights into chlorination-induced degradation of sulfonylurea herbicides: Unraveling kinetics and intermediates during water treatment. Water Research. 280. 123513–123513. 2 indexed citations
2.
Iacovelli, Roberto, Emanuela Fantinel, Davide Bimbatti, et al.. (2024). Efficacy of perioperative pembrolizumab treatment in patients with resectable metastases from kidney cancer: The PE-PE study.. Journal of Clinical Oncology. 42(4_suppl). TPS495–TPS495.
3.
4.
5.
Rescigno, Pasquale, Marco Maruzzo, Sara Elena Rebuzzi, et al.. (2022). Adherence to oral treatments in elderly patients with advanced prostate cancer: The ADHERE study, a prospective trial of the Meet-URO network.. Journal of Clinical Oncology. 40(16_suppl). 12044–12044. 1 indexed citations
6.
Barlati, Sergio, Gabriele Nibbio, Alessandra Mosca, et al.. (2022). Autistic Symptoms in Schizophrenia: Impact on Internalized Stigma, Well-Being, Clinical and Functional Characteristics. Frontiers in Psychiatry. 13. 801651–801651. 13 indexed citations
7.
Conteduca, Vincenza, Alessandra Mosca, Nicole Brighi, Ugo De Giorgi, & Pasquale Rescigno. (2021). New Prognostic Biomarkers in Metastatic Castration-Resistant Prostate Cancer. Cells. 10(1). 193–193. 33 indexed citations
8.
Mennitto, Alessia, Elena Verzoni, Francesco Cognetti, et al.. (2021). Radical metastasectomy followed by sorafenib versus observation in patients withclear cell renal cell carcinoma: extended follow -up of efficacy results from the randomized phase II RESORT trial. Expert Review of Clinical Pharmacology. 14(2). 261–268. 7 indexed citations
9.
Rossi, Ernesto, Melissa Bersanelli, Alain Gelibter, et al.. (2021). Combination Therapy in Renal Cell Carcinoma: the Best Choice for Every Patient?. Current Oncology Reports. 23(12). 147–147. 18 indexed citations
10.
Checcucci, Enrico, Stefano De Luca, Federico Piramide, et al.. (2021). The real-time intraoperative guidance of the new HIFU Focal-One® platform allows to minimize the perioperative adverse events in salvage setting. Journal of Ultrasound. 25(2). 225–232. 4 indexed citations
11.
Soria, Francesco, Alessandra Mosca, & Paolo Gontero. (2019). Drug strategies for bladder cancer in the elderly: is there promise for the future?. Expert Opinion on Pharmacotherapy. 20(11). 1387–1396. 2 indexed citations
12.
Claps, Mélanie, Fausto Petrelli, Orazio Caffo, et al.. (2018). Testosterone Levels and Prostate Cancer Prognosis: Systematic Review and Meta-analysis. Clinical Genitourinary Cancer. 16(3). 165–175.e2. 34 indexed citations
13.
Sbrana, Andrea, Elisa Biasco, Claudia Caserta, et al.. (2018). Long-term Response to First-line Pazopanib Therapy in mRCC Patients: A Multicenter Italian Experience. Anticancer Research. 38(8). 4913–4918. 3 indexed citations
14.
Dragoni, Silvia, Ilaria Turin, Umberto Laforenza, et al.. (2014). Store-Operated Ca2+Entry Does Not Control Proliferation in Primary Cultures of Human Metastatic Renal Cellular Carcinoma. BioMed Research International. 2014. 1–19. 55 indexed citations
15.
Gelardi, Matteo, Giovanni Passalacqua, Maria Luisa Fiorella, Alessandra Mosca, & Nicola Quaranta. (2011). Nasal cytology: the “infectious spot”, an expression of a morphological-chromatic biofilm. European Journal of Clinical Microbiology & Infectious Diseases. 30(9). 1105–1109. 25 indexed citations
16.
Berruti, Alfredo, Alessandra Mosca, Marco Tucci, et al.. (2005). Independent prognostic role of circulating chromogranin A in prostate cancer patients with hormone-refractory disease. Endocrine Related Cancer. 12(1). 109–117. 106 indexed citations
17.
Berruti, Alfredo, Marco Tucci, Alessandra Mosca, et al.. (2005). Predictive factors for skeletal complications in hormone-refractory prostate cancer patients with metastatic bone disease. British Journal of Cancer. 93(6). 633–638. 52 indexed citations
18.
Berruti, Alfredo, Luigi Dogliotti, Alessandra Mosca, et al.. (2001). Potential clinical value of circulating chromogranin A in patients with prostate carcinoma. Annals of Oncology. 12. S153–S157. 38 indexed citations
19.
Bollito, Enrico, Alessandra Mosca, E Leonardo, et al.. (2001). Relationship between neuroendocrine features and prognostic parameters in human prostate adenocarcinoma. Annals of Oncology. 12. S159–S164. 59 indexed citations
20.
Berruti, Alfredo, Luigi Dogliotti, Alessandra Mosca, et al.. (2000). Circulating neuroendocrine markers in patients with prostate carcinoma. Cancer. 88(11). 2590–2597. 105 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Li Cai Breakdown of academic impact, for papers by Mauro Bologna Breakdown of academic impact, for papers by Jie Liu Breakdown of academic impact, for papers by Mohd W. Nasser Breakdown of academic impact, for papers by Hiroshi Matsui Breakdown of academic impact, for papers by Wassim Abou‐Kheir Breakdown of academic impact, for papers by Alessandra Ghigo Breakdown of academic impact, for papers by Xiao‐Feng Zhu Breakdown of academic impact, for papers by Chong Zhang Breakdown of academic impact, for papers by Songqing He
Rankless by CCL
2026